Latest / Charleston News Today | 2 Min News | The Daily News Now!
SETD2 Mutation Reveals New Kidney Cancer Target | Charleston News
Scientists at the Medical University of South Carolina uncovered a game-changing insight into aggressive kidney cancer: tumors with a broken SETD2 gene become fatally dependent on one protein, making it a prime new drug target. This discovery could lead to treatments that spare healthy cells and halt cancer spread — backed by a $3 million NIH grant to accelerate research. While clinical trials are still ahead, this breakthrough offers fresh hope for patients with few options, proving that sometimes science finds its biggest answers when chasing smaller ones. Listen in comfort:Get a discount…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.